Novel Coronavirus (SARS-CoV-2/COVID-19)
Oklahoma voters approved expanding the state’s Medicaid initiative, the first state to do so during the COVID-19 pandemic. The ballot question, which passed with nearly 50.5% of the vote, initiates a state constitutional amendment to provide Medicaid to those with incomes at or below 138% of the…
The Food and Drug Administration issued guidance for the development of a SARS-CoV-2 vaccine, outlining key considerations to satisfy requirements for chemistry, manufacturing and control, nonclinical and clinical data.
The Department of Health and Human Services announced the reestablishment of the Ready Reserve Corps, a uniformed services that provides trained and ready personnel available on short notice to fill critical public health needs.
Hospitals face a triple threat with financial losses due to COVID-19, AHA President and CEO said on CNBC.
The Senate passed by unanimous consent legislation (S. 4116) extending the Paycheck Protection Program loan application period through Aug. 8. It’s unclear if the House will take up the legislation before the July 4th recess.
Please reach out to your senators during the July 4 district work period
As Congress considers additional COVID-19 relief actions, we need to make sure hospital and health systems' priorities are at the top of its list.
The Food and Drug Administration authorized the emergency use of two COVID-19 molecular diagnostic tests. The tests from Inform Diagnostics Inc. and Diagnostic Solutions Laboratory LLC detect in respiratory specimens nucleic acid from SARS-CoV-2, the virus that causes COVID-19.
Three of the five most effective cloth face coverings tested by the National Institute of Standards and Technology were 100% cotton and had a visible raised fiber or nap, such as found on flannels, the agency announced.
More than 350 hospital and health system leaders from across the country this afternoon participated in an AHA Virtual Advocacy Day to urge senators to include priorities that support hospitals and health systems in the next COVID-19 legislative package.